6-K 1 dp100050_6k-potash.htm FORM 6-K

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of December, 2018

Commission File Number: 001-13742

ISRAEL CHEMICALS LTD.

(Exact name of registrant as specified in its charter)

Israel Chemicals Ltd.

Millennium Tower

23 Aranha Street

P.O. Box 20245

Tel Aviv, 61202 Israel

(972-3) 684-4400

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F X Form 40-F

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

Yes No X

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

Yes No X

ISRAEL CHEMICALS LTD.

INCORPORATION BY REFERENCE

This report on Form 6-K shall be deemed to be incorporated by reference into the registration statement on Form S-8 (Registration Number: 333-205518) of Israel Chemicals Ltd. and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.

ISRAEL CHEMICALS LTD.

1. ICL Signs a Five Year Framework Agreement for the Sale of Potash in India

Item 1

ICL Signs a Five Year Framework Agreement for the Sale of Potash in India

The Company hereby announces that it signed, for the first time, a five-year supply agreement with Indian Potash Limited (“IPL”), India’s largest importer of potash. According to the agreement, ICL is expected to supply IPL with 600,000 tonnes per year in 2019 and 2020, increasing to 650,000 tonnes per year in 2021-2023, including options. Prices for the quantities to be supplied under the framework agreement shall be determined in accordance with the prevailing market prices in India at the relevant date of supply.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

			Israel Chemicals Ltd.
			By:	/s/ Kobi Altman
				Name:	Kobi Altman
				Title:	Chief Financial Officer

			Israel Chemicals Ltd.
			By:	/s/ Lisa Haimovitz
				Name:	Lisa Haimovitz
				Title:	Senior Vice President and Global General Counsel

Date: December 27, 2018